Targeted Host Cell Protein Quantification by LC-MRM Enables Biologics Processing and Product Characterization
Xinliu Gao1, Baibhav Rawal1, Yi Wang1
1Analytical Research & Development Mass Spectrometry , Merck & Company Incorporated , 2000 Galloping Hill Road , Kenilworth , New Jersey 07033 , United States.
Analytical Chemistry
|December 21, 2019
Summary
This study introduces a multiplex LC-MRM assay to quantify high-risk host cell proteins (HCPs) like PLBL2 and LPLA2 in biologics. The validated assay effectively monitors HCP clearance during bioprocess development, aiding product quality control.
Area of Science:
- Biopharmaceutical analysis
- Mass spectrometry
- Protein quantification
Background:
- Multiple Reaction Monitoring (MRM) is a sensitive LC-MS technique widely used in pharma for molecule quantification.
- Its application for quantifying specific host cell proteins (HCPs) in bioprocesses remains underexplored.
- HCPs can impact biologics product quality, necessitating robust monitoring methods.
Purpose of the Study:
- To develop and validate a multiplex LC-MRM assay for simultaneous quantification of two high-risk lipases (PLBL2 and LPLA2).
- To assess the assay's performance for monitoring lipase clearance during biologics process development.
- To evaluate the impact of HCP-mAb interactions on lipase quantification.
Main Methods:
- Development of a multiplex LC-MRM assay targeting PLBL2 and LPLA2.
- Method qualification including linearity, precision, accuracy, selectivity, recovery, matrix effect, dilution linearity, and carryover.
- Comparison of direct digestion and affinity depletion platforms for HCP quantification.
Main Results:
- The LC-MRM assay demonstrated linearity over a dynamic range of 1 to 500 ng/mg.
- Comprehensive method qualification confirmed the assay's fitness for use and robustness.
- The assay effectively monitored the clearance of PLBL2 and LPLA2 during process development.
- Comparison revealed the impact of HCP-mAb interaction on lipase quantification.
Conclusions:
- The developed multiplex LC-MRM assay is a rapid and accurate tool for monitoring high-risk HCP clearance in bioprocesses.
- This assay can actively guide process improvement and optimization for enhanced biologics quality.
- Understanding HCP-mAb interactions is crucial for accurate lipase quantification.


